
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
INDV | London | GBP | Real-time | |
INDVl | BATS Europe | GBP | Delayed | |
INDV | NASDAQ | USD | Real-time | |
2IVB | TradeGate | EUR | Delayed | |
2IVB | Frankfurt | EUR | Delayed |
Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its SUBLOCADE, SUBUTEX and SUBOXONE are used for the treatment of opioid use disorder (OUD). Its PERSERIS is used for the treatment of Schizophrenia. The Company's pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet, and Buprenorphine Sublingual Tablet, OPNT003, OPNT002, and OPNT004.
Name | Age | Since | Title |
---|---|---|---|
Mark Crossley | - | 2014 | CEO & Executive Director |
Peter James Jonathan Bains | 64 | 2019 | Independent Non-Executive Director |
Ryan Preblick | - | 2020 | CFO & Executive Director |
Graham C. Hetherington | 64 | 2019 | Independent Chairman |
Juliet Thompson | 57 | 2021 | Senior Independent Director |
Jerome Jay Lande | 47 | 2021 | Non-Executive Director |
Mark P. Stejbach | 60 | 2021 | Independent Non-Executive Director |
Joanna Susan Le Couilliard | 60 | 2021 | Independent Non-Executive Director |
Barbara A. Ryan | 63 | 2022 | Independent Non-Executive Director |
A. Thomas McLellan | - | 2014 | Non-Executive Director |
Keith Humphreys | - | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review